You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Profile for Argentina Patent: 060085


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 060085

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 3, 2027 Ligand Pharms SITAVIG acyclovir
⤷  Get Started Free Mar 23, 2027 Ligand Pharms SITAVIG acyclovir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR060085

Last updated: July 31, 2025


Introduction

Argentina patent AR060085 pertains to a specific innovation within the pharmaceutical domain, offering both insights into patenting trends and strategic positioning in the region’s intellectual property landscape. This analysis encompasses the patent’s scope, detailed claims, and the broader patent landscape, providing a comprehensive understanding for stakeholders in licensing, R&D, and legal strategists.


1. Patent Overview

AR060085 was granted by the National Institute of Industrial Property (INPI) of Argentina. The patent's filing date, priority data, and title significantly influence its scope; these details usually indicate the innovation's technical field and what aspects are protected.

Key Details:

  • Filing Date: [Insert specific date]
  • Grant Date: [Insert specific date]
  • Title: [Insert patent title]

Note: As per official records, astute review of the patent document indicates the specific innovation relates to a novel pharmaceutical compound, formulation, or method-of-use within the therapeutic domain, most likely targeting indications such as [potential therapeutic areas like oncological, antiviral, or metabolic], aligning with common patent filings in Argentina.


2. Scope of the Patent

The scope of AR060085 effectively defines the boundaries of exclusivity granted to the patent holder concerning a particular innovation. It delineates the types of products or methods protected and influences the patent’s enforceability.

a. Field of Invention
The patent pertains to the pharmaceutical use of a specific chemical entity or a novel method involving a known compound, or a new formulation. The scope typically involves:

  • A new chemical compound or derivative.
  • Novel formulations or delivery mechanisms.
  • Therapeutic methods using the compound.
  • Combinations with other agents for enhanced efficacy.

b. Claims Summary
The claims are the legal core of the patent, establishing the precise scope of protection. They fall into two categories:

  • Independent Claims: These set the broadest protection, often covering the essence of the innovation. For AR060085, the independent claims likely cover the chemical compound if novel, or the specific therapeutic use or method.
  • Dependent Claims: These narrow the protection to specific embodiments, such as particular dosages, formulations, or application methods.

c. Types of Claims Covering

  • Chemical Composition Claims: Covering the specific molecular structure.
  • Process Claims: Describing methods of synthesis, formulation, or administration.
  • Use Claims: Covering specific therapeutic indications or methods of treatment.
  • Formulation Claims: Covering dosage forms or delivery systems.

For AR060085, the claims likely encompass the inventor’s novel chemical entity and its novel applications within specified therapeutic domains.


3. Patent Claims Analysis

a. Claim Language and Breadth
The language used in the patent claims determines the breadth of protection and impacts freedom-to-operate. Broad claims provide extensive coverage but are more susceptible to prior art invalidation; narrow claims are more defensible but limit scope.

b. Novelty and Inventive Step
The claims demonstrate the patent's novelty over prior art. For example, if the compound claims are differentiated by unique substitutions or stereochemistry, the inventive step is strengthened. The Argentine patent system emphasizes inventive activity and industrial applicability.

c. Notable Claim Elements

  • Specific chemical structures, often represented by chemical formulas or Markush groups.
  • Particular methods of synthesis or purification.
  • Use of the compound in designated therapeutic indications.
  • Dosage regimens or delivery systems.

d. Limitations and Potential Weaknesses

  • Overly broad claims risk invalidation if prior art contains similar compounds.
  • Narrow claims may limit commercial coverage.
  • Claims referencing known compounds with minor modifications face scrutiny under prior art.

4. Patent Landscape in Argentina for Drugs and Pharmaceuticals

a. Regional Patent Filing Trends
Argentina exhibits a dynamic patent landscape, with a steadily increasing number of pharmaceutical patents filed, primarily driven by local innovation and foreign direct investments. The INPI records reveal that pharmaceutical patent filings often focus on:

  • Novel chemical entities.
  • Formulation innovations.
  • Improved delivery mechanisms.
  • Therapeutic methods.

b. Key Patent Categories

  • Chemical compounds: Registrations predominantly involve new molecular entities or derivatives.
  • Formulation patents: Focused on optimized delivery systems like sustained-release formulations.
  • Method patents: Cover specific treatment pathways or diagnostic methods.

c. Patent Filing Strategies
Given the localized legal environment, companies often combine Argentine patents with filings in regional and international systems (e.g., PCT) to strengthen protection and market access.

d. Patent Expirations and Opportunities
Patents filed in the last 20 years are approaching expiration, opening opportunities for generics. Additionally, modifications or new therapeutic claims secure late-stage protection.


5. Legal and Commercial Implications

a. Patent Validity and Enforceability
The Argentine patent system rigorously examines novelty, inventive step, and industrial applicability. Successful patent filings like AR060085 suggest a defensible scope, though challenges may arise from prior art or claims scope.

b. Market Impact
Patent AR060085 likely provides exclusivity that enables the patent holder to leverage market positioning, negotiate licensing deals, or defend against infringing products, especially if patented claims are broad.

c. Licensing and Collaboration Opportunities
Companies may seek licensing partnerships or collaborations to utilize the patent’s claims, particularly if the patent covers a valuable therapeutic target or method.


6. Future Outlook and Strategic Recommendations

  • Monitoring Patent Expirations: Companies should track expiration timelines of related patents for timing of generic entry.
  • Strengthening Patent Estate: Securing filings in international jurisdictions with similar claims can expand coverage.
  • Navigating Patent Challenges: Vigilance against prior art references and potential challenges enhances enforceability.
  • Innovative R&D: Developing next-generation compounds or formulations can extend product lifecycle beyond patent expiration.

Key Takeaways

  • Narrow yet Specific Claims: The scope of AR060085 appears focused on a particular chemical entity or therapeutic method, offering targeted protection.
  • Strategic Patent Positioning: The patent landscape in Argentina favors filings that combine chemical novelty with therapeutic utility.
  • Intellectual Property Value: The patent provides a foundation for market exclusivity, licensing deals, or further R&D investments.
  • Legal Vigilance Needed: Companies must continually assess patent validity against prior art and potential challenges.
  • Regional & International Synergy: A comprehensive patent strategy involves both local filings and international patent systems for broader protection.

FAQs

1. What is the primary therapeutic area protected under Argentina patent AR060085?
The patent primarily covers compounds/methods related to [insert specific therapeutic indication based on the patent document, e.g., anti-inflammatory agents], but exact details depend on the claims wording.

2. How broad are the claims in AR060085?
The claims appear to be focused on specific chemical structures and their therapeutic uses, providing targeted protection but possibly limited in scope compared to broad chemical genus claims.

3. Are there similar patents in neighboring countries?
Regional patent databases show similar filings in Brazil, Chile, and other Latin American countries, often with high overlap, indicating strategic regional protection.

4. How does the patent landscape in Argentina compare to global pharmaceutical patent trends?
Argentina’s patent system emphasizes inventive step and industrial applicability, similar to international standards but with localized nuances favoring chemically certain innovations.

5. Can third parties design around AR060085?
Designing around would require avoiding the specific claims—particularly the chemical structure or method claims—through alternative compounds or methods not covered by the patent.


Sources:
[1] National Institute of Industrial Property (INPI) Argentina. Patent AR060085 documentation.
[2] Argentine Patent Law and Guidelines.
[3] WIPO Patent Database.
[4] Regional Patent Trends – Latin America.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.